{"count": 5, "results": [{"_id": "33979807", "pmid": 33979807, "title": "Comparison of Insulin, Metformin, and Glyburide on Perinatal Complications of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis.", "journal": "Gynecol Obstet Invest", "authors": ["Wang X", "Liu W", "Chen H", "Chen Q"], "date": "2021-01-01T00:00:00Z", "doi": "10.1159/000515893", "meta_date_publication": "2021", "meta_volume": "86", "meta_issue": "3", "meta_pages": "218-230", "score": 50258.066, "text_hl": "Comparison of @GENE_INS @GENE_3630 @@@Insulin@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, and @CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@Glyburide@@@ on @<m>DISEASE_Perinatal_Death</m> @DISEASE_MESH:D066087 @@@Perinatal Complications@@@ of @DISEASE_Diabetes_Gestational @DISEASE_MESH:D016640 @@@Gestational Diabetes Mellitus@@@: A Systematic Review and Meta-Analysis.", "citations": {"NLM": "Wang X, Liu W, Chen H, Chen Q. Comparison of Insulin, Metformin, and Glyburide on Perinatal Complications of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis. Gynecol Obstet Invest. 2021;86(3):218-230. PMID: 33979807", "BibTeX": "@article{33979807, title={Comparison of Insulin, Metformin, and Glyburide on Perinatal Complications of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis.}, author={Wang X and Liu W and Chen H and Chen Q}, journal={Gynecol Obstet Invest}, volume={86}, number={3}, pages={218-230}}"}}, {"_id": "20075550", "pmid": 20075550, "title": "Metformin--a convenient alternative to insulin for Indian women with diabetes in pregnancy.", "journal": "Indian J Med Sci", "authors": ["Rai L", "Meenakshi D", "Kamath A"], "date": "2009-11-01T00:00:00Z", "meta_date_publication": "2009 Nov", "meta_volume": "63", "meta_issue": "11", "meta_pages": "491-7", "score": 50059.14, "text_hl": "The outcome measures studied were glycemic control, maternal complications and @<m>DISEASE_Perinatal_Death</m> @DISEASE_MESH:D066087 @@@perinatal@@@ outcome. RESULTS: Sixty @SPECIES_9606 @@@women@@@ with @DISEASE_Diabetes_Gestational @DISEASE_MESH:D016640 @@@gestational and type 2 diabetes@@@ were enrolled, 30 each for @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @GENE_INS @GENE_3630 @@@insulin@@@. ", "citations": {"NLM": "Rai L, Meenakshi D, Kamath A. Metformin--a convenient alternative to insulin for Indian women with diabetes in pregnancy. Indian J Med Sci. 2009 Nov;63(11):491-7. PMID: 20075550", "BibTeX": "@article{20075550, title={Metformin--a convenient alternative to insulin for Indian women with diabetes in pregnancy.}, author={Rai L and Meenakshi D and Kamath A}, journal={Indian J Med Sci}, volume={63}, number={11}, pages={491-7}}"}}, {"_id": "30039871", "pmid": 30039871, "title": "Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.", "journal": "Cochrane Database Syst Rev", "authors": ["Dodd JM", "Grivell RM", "Deussen AR", "Hague WM"], "date": "2018-07-24T00:00:00Z", "doi": "10.1002/14651858.CD010564.pub2", "meta_date_publication": "2018 Jul 24", "meta_volume": "7", "meta_issue": "7", "meta_pages": "CD010564", "score": 50038.72, "text_hl": "There were no other important differences identified for other infant secondary outcomes in this review: hypoglycaemia (@DISEASE_Hypotension @DISEASE_MESH:D007022 @@@low blood sugar@@@); hyperbilirubinaemia (@DISEASE_Jaundice @DISEASE_MESH:D007565 @@@jaundice@@@); Apgar score less than 7 at five minutes; or @DISEASE_Stillbirth @DISEASE_MESH:D050497 @@@stillbirth@@@ and @<m>DISEASE_Perinatal_Death</m> @DISEASE_MESH:D066087 @@@neonatal death@@@. Only one study reported admission to the neonatal intensive care unit (NICU), indicating similar rates of admission between @SPECIES_9606 @@@women@@@ receiving @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ or placebo; no other admission data were reported to assess differences in costs. ", "citations": {"NLM": "Dodd JM, Grivell RM, Deussen AR, Hague WM. Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes. Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. PMID: 30039871", "BibTeX": "@article{30039871, title={Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.}, author={Dodd JM and Grivell RM and Deussen AR and Hague WM}, journal={Cochrane Database Syst Rev}, volume={7}, number={7}, pages={CD010564}}"}}, {"_id": "20868615", "pmid": 20868615, "title": "Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee.", "journal": "Health Technol Assess", "authors": ["Waugh N", "Royle P", "Clar C", "Henderson R", "Cummins E", "Hadden D", "Lindsay R", "Pearson D"], "date": "2010-09-01T00:00:00Z", "doi": "10.3310/hta14450", "meta_date_publication": "2010 Sep", "meta_volume": "14", "meta_issue": "45", "meta_pages": "1-183", "score": 50029.777, "text_hl": "The exceptions were that there was less maternal hypoglycaemia with @CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@glibenclamide@@@, but less @DISEASE_Infant_Newborn_Diseases @DISEASE_MESH:D007232 @@@neonatal hypoglycaemia@@@ and lower birthweight with @GENE_INS @GENE_3630 @@@insulin@@@, and there was less maternal @DISEASE_Weight_Gain @DISEASE_MESH:D015430 @@@weight gain@@@ with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. The ACHOIS and MFMUN trials showed reductions in @<m>DISEASE_Perinatal_Death</m> @DISEASE_MESH:D066087 @@@perinatal@@@ complications among infants born to mothers who were provided with more intensive dietary advice, @CHEMICAL_Blood_Glucose @CHEMICAL_MESH:D001786 @@@blood glucose@@@ monitoring and @GENE_INS @GENE_3630 @@@insulin@@@ when required. ", "citations": {"NLM": "Waugh N, Royle P, Clar C, Henderson R, Cummins E, Hadden D, Lindsay R, Pearson D. Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee. Health Technol Assess. 2010 Sep;14(45):1-183. PMID: 20868615", "BibTeX": "@article{20868615, title={Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee.}, author={Waugh N and Royle P and Clar C and Henderson R and Cummins E and Hadden D and Lindsay R and Pearson D}, journal={Health Technol Assess}, volume={14}, number={45}, pages={1-183}}"}}, {"_id": "29103210", "pmid": 29103210, "title": "Insulin for the treatment of women with gestational diabetes.", "journal": "Cochrane Database Syst Rev", "authors": ["Brown J", "Grzeskowiak L", "Williamson K", "Downie MR", "Crowther CA"], "date": "2017-11-05T00:00:00Z", "doi": "10.1002/14651858.CD012037.pub2", "meta_date_publication": "2017 Nov 5", "meta_volume": "11", "meta_issue": "11", "meta_pages": "CD012037", "score": 50017.48, "text_hl": "There was no clear evidence of difference in postnatal weight retention between @SPECIES_9606 @@@women@@@ treated with @GENE_INS @GENE_3630 @@@insulin@@@ and those treated with oral anti-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ pharmacological therapy (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@) at six to eight weeks postpartum (MD -1.60 kg, 95% CI -6.34 to 3.14; one study, 167 @SPECIES_9606 @@@women@@@; low-quality evidence) or one year postpartum (MD -3.70, 95% CI -8.50 to 1.10; one study, 176 @SPECIES_9606 @@@women@@@; low-quality evidence). ", "citations": {"NLM": "Brown J, Grzeskowiak L, Williamson K, Downie MR, Crowther CA. Insulin for the treatment of women with gestational diabetes. Cochrane Database Syst Rev. 2017 Nov 5;11(11):CD012037. PMID: 29103210", "BibTeX": "@article{29103210, title={Insulin for the treatment of women with gestational diabetes.}, author={Brown J and Grzeskowiak L and Williamson K and Downie MR and Crowther CA}, journal={Cochrane Database Syst Rev}, volume={11}, number={11}, pages={CD012037}}"}}]}